Literature DB >> 15158266

Generation of Leishmania mutants lacking antibiotic resistance genes using a versatile hit-and-run targeting strategy.

Hubert Denise1, Graham H Coombs, Jeremy C Mottram.   

Abstract

The development of a method to create defined mutants of Leishmania parasites lacking foreign genes conferring resistance to antibiotics has both experimental and practical applications. Mutants deficient in specific virulence genes have potential as attenuated live vaccines, but these can only be of clinical relevance if the antibiotic resistance genes used for selection of the mutants are subsequently removed. In addition, the limited number of antibiotic resistance genes that can be used for genetic manipulation of Leishmania means that a system for recycling them for subsequent use would be highly beneficial when multiple genetic modifications are wanted. In the method we report here, a cassette carrying in tandem the hygromycin resistance gene as a positive marker and thymidine kinase gene as a negative marker is first integrated into the locus of interest and then replaced by a null targeting fragment containing no exogenous DNA. The application of this hit-and-run strategy for removal of one allele of the CPB cysteine peptidase gene array of Leishmania infantum is described.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15158266     DOI: 10.1016/j.femsle.2004.04.015

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  8 in total

1.  CRE recombinase-based positive-negative selection systems for genetic manipulation in Trypanosoma brucei.

Authors:  Michael D Scahill; Irena Pastar; George A M Cross
Journal:  Mol Biochem Parasitol       Date:  2007-10-06       Impact factor: 1.759

2.  The genetic toolbox for Leishmania parasites.

Authors:  Sigrid C Roberts
Journal:  Bioeng Bugs       Date:  2011-11-01

3.  Leishmaniasis Vaccine: Where are We Today?

Authors:  Lukasz Kedzierski
Journal:  J Glob Infect Dis       Date:  2010-05

Review 4.  Visceral leishmaniasis: experimental models for drug discovery.

Authors:  Suman Gupta
Journal:  Indian J Med Res       Date:  2011-01       Impact factor: 2.375

5.  Leishmania amastigotes as targets for drug screening.

Authors:  Adriano Monte-Alegre; Ali Ouaissi; Denis Sereno
Journal:  Kinetoplastid Biol Dis       Date:  2006-10-23

6.  Studies on the CPA cysteine peptidase in the Leishmania infantum genome strain JPCM5.

Authors:  Hubert Denise; Jacqueline Poot; Maribel Jiménez; Audrey Ambit; Daland C Herrmann; Arno N Vermeulen; Graham H Coombs; Jeremy C Mottram
Journal:  BMC Mol Biol       Date:  2006-11-13       Impact factor: 2.946

Review 7.  Biomarkers of safety and immune protection for genetically modified live attenuated leishmania vaccines against visceral leishmaniasis - discovery and implications.

Authors:  Sreenivas Gannavaram; Ranadhir Dey; Kumar Avishek; Angamuthu Selvapandiyan; Poonam Salotra; Hira L Nakhasi
Journal:  Front Immunol       Date:  2014-05-23       Impact factor: 7.561

8.  Using a non-image-based medium-throughput assay for screening compounds targeting N-myristoylation in intracellular Leishmania amastigotes.

Authors:  Daniel Paape; Andrew S Bell; William P Heal; Jennie A Hutton; Robin J Leatherbarrow; Edward W Tate; Deborah F Smith
Journal:  PLoS Negl Trop Dis       Date:  2014-12-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.